North America Tissue Engineering Market

The tissue engineering market in North America is expected to grow from US$ 6,242.13 million in 2021 to US$ 14,218.20 million by 2028; it is estimated to grow at a CAGR of 12.5% from 2021 to 2028.

3D bioprinting has rapidly transformed the healthcare sector in the last few years. The technology has advanced the tissue development with clinical potential, paving the way for high-throughput applications for drug discovery. 3D bioprinting tissue-engineering helps in the healing of injuries. With new breakthroughs in the 3D printing technique, many research organizations are working toward finding new therapies to treat organ failure and repair damaged tissue cells. For instance, in 2017, researchers at Penn State University discovered a revolutionary way to print tissues and organs with the use of an “electrospinning printer”. The printer spins fibers seeded with cells to create fiber layers. The technology is cost-effective and offers an opportunity to spin polymer fibers, such as collagen layers, with precision and in a controlled manner. In addition, scientists at George R. Brown School of Engineering reported the construction of a 3D printed organ that mimics lungs. In April 2019, a researcher at Tel Aviv University printed the world’s first 3D engineered, vascularized heart using a patient’s own cells and biological materials. With advances in stem cell research, intelligent biomaterials, and three-dimensional biofabrication strategies, highly mimicked tissues or organs can be engineered. In future, there would be advances in bioprinting, including the integration of different printing mechanisms to produce biphasic or triphasic tissues with optimized scaffolds and a further understanding of stem cell biology. Recently, 3D printing has promised tissue manufacturing with micro- to macro-scale structural control through a layer-by-layer approach. Through 3D reconstructions of scanned lesions, bioprinting can precisely deliver cells, growth factors, and biomaterial scaffolds to repair the lesion with different shapes and thicknesses. A promising direction is to combine the bioprinting approaches based on other mechanisms to meet the various challenges. Government funding for research activities is increasing. For instance, as per the National Institutes of Health (NIH) funding study in the US, the research studies pertaining to stem cell and regenerative medicines received funding of US$ 1.8 and US$ 1.0 billion in 2018, respectively.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America tissue engineering market at a substantial CAGR during the forecast period.

North America Tissue Engineering Market Revenue and Forecast to 2028 (US$ Million)  

North America Tissue Engineering Market Segmentation

The North America tissue engineering market is segmented on the basis of material type, application, and country. Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2021, the biologically derived materials segment held the largest market share. However, the synthetic materials segment is expected to register the highest CAGR during the forecast period. Based on application, the market is segmented into orthopedic, musculoskeletal & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi & gynecology, urology, and others. In 2021, the orthopedic, musculoskeletal, & spine segment held the largest market share. However, the skin & integumentary segment is expected to register the highest CAGR in the market during the forecast period. Based on country, the North America tissue engineering market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021 and is expected to register the highest CAGR during the forecast period.

Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Organogenesis Inc.; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the North America tissue engineering market.